Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-25 @ 2:37 AM
NCT ID:
NCT00004934
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven stage IIB, III, or IV invasive ovarian epithelial, fallopian tube, or peritoneal cancer
* No symptomatic brain metastasis
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* WHO/ECOG 0-2
Life expectancy:
* Not specified
Hematopoietic:
* WBC at least 3,000/mm\^3
* Neutrophil count at least 1,500/mm\^3
* Platelet count at least 100,000/mm\^3
Hepatic:
* Bilirubin no greater than 2 times upper limit of normal
Renal:
* Glomerular filtration rate at least 50 mL/min
Cardiovascular:
* No ventricular arrhythmia (LOWN class II or worse)
* No myocardial infarction within the past year
* No severe or uncontrolled hypertension
* No history of congestive heart disease (no New York Heart Association class III or IV heart disease) even if medically controlled
* LVEF at least 50%
Other:
* No other primary malignancies except carcinoma in situ of the cervix or basal cell skin cancer
* No worse than grade I preexisting motor or sensory neurologic pathology or symptoms
* No active infection or other serious underlying medical condition that would prevent compliance
* Not pregnant or nursing
* Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* No prior chemotherapy
* No other concurrent antineoplastic agents
Endocrine therapy:
* Not specified
Radiotherapy:
* No prior radiotherapy
Surgery:
* Not specified
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00004934
Study Brief:
Protocol Section:
NCT00004934